4//SEC Filing
Kirschbaum Mark 4
Accession 0001104659-23-009908
CIK 0001130166other
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 4:17 PM ET
Size
5.0 KB
Accession
0001104659-23-009908
Insider Transaction Report
Form 4
Kirschbaum Mark
Chief Medical Officer
Transactions
- Award
Common Stock
2023-01-31+31,200→ 31,200 total
Footnotes (1)
- [F1]The reporting person received an award of 31,200 restricted stock units on January 31, 2023, which shall vest in full on January 31, 2026, provided, however, that if certain clinical milestones are achieved then such restricted stock units shall vest in full earlier in connection with such achievement.
Documents
Issuer
Cyclacel Pharmaceuticals, Inc.
CIK 0001130166
Entity typeother
Related Parties
1- filerCIK 0001830211
Filing Metadata
- Form type
- 4
- Filed
- Feb 1, 7:00 PM ET
- Accepted
- Feb 2, 4:17 PM ET
- Size
- 5.0 KB